Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
2014
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
HIV rebounds from latently infected cells, rather than from continuing low-level replication
2008
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
2009
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Investigating Signs of Recent Evolution in the Pool of Proviral HIV Type 1 DNA during Years of Successful HAART
2007
Neurocysticercosis: an update
2002
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
2007
Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes
2008
Effect of maternal CD4 + cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection
1997
EMERGEncy ID NET: An Emergency Department–Based Emerging Infections Sentinel Network
1998
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes
2007
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
2000 Standout
The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance
2007
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs
2010
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Echinococcosis
2003 Standout
Human and porcine Taenia solium infection in a village in the highlands of Cusco, Peru
1999
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
2003
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
2012 Nature
HIV vaccines 1983–2003
2003
Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis
1996
A specific antigen-detection elisa for the diagnosis of human neurocysticercosis
1998
Taenia solium cysticercosis
2003 Standout
Effect of Treatment, during Primary Infection, on Establishment and Clearance of Cellular Reservoirs of HIV-1
2005
Generation of HIV latency during thymopoiesis
2001
Metastasis prevention by targeting the dormant niche
2015
RNA silencing: no mercy for viruses?
2004
Serologic and molecular diagnosis of zoonotic larval cestode infections
2002
NF-κB-inducing Kinase and IκB Kinase Participate in Human T-cell Leukemia Virus I Tax-mediated NF-κB Activation
1998
Parenchymal neurocysticercosis: follow-up and staging by MRI
1997
Higher-Order Oligomerization Targets Plasma Membrane Proteins and HIV Gag to Exosomes
2007
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Effects of diterpenes from latex of Euphorbia lactea and Euphorbia laurifolia on human immunodeficiency virus type 1 reactivation
2009
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
2010
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Epidemiology of intestinal taeniasis in four, rural, Guatemalan communities
1996
Therapy for Neurocysticercosis: A Reappraisal
1993
Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy
2010
The end of AIDS: HIV infection as a chronic disease
2013 Standout
TAENIA SOLIUM CYSTICERCOSIS
2000
Emerging Biological Principles of Metastasis
2017 Standout
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART
2005
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
2006 Standout
HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration
2007
Signaling to NF-κB
2004 Standout
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins
2005
The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila
2005 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Magnitude of the Disease Burden from Neurocysticercosis in a Developing Country
1999
Herpes Zoster
2013 Standout
Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry
2005
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
2003 Standout
Macrophages archive HIV‐1 virions for dissemination in trans
2005
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Where Does HIV Live?
2004
Serologic Evolution of Neurocysticercosis Patients after Antiparasitic Therapy
1997
Epilepsy and neurocysticercosis in an Andean community
1999
HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy
2001
The multifactorial nature of HIV-1 latency
2004
Food-Related Illness and Death in the United States
1999 Standout
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
2008
Exosomes
2019 Standout
Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection
2013
The Challenge of Finding a Cure for HIV Infection
2009 Science
Exosomes Packaging APOBEC3G Confer Human Immunodeficiency Virus Resistance to Recipient Cells
2008
Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins
2011
Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
2006
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Neurocysticercosis: Updates on Epidemiology, Pathogenesis, Diagnosis, and Management
2000
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus
2005
CRISPR-Cas: biology, mechanisms and relevance
2016 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2014
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
2014 StandoutNobel
Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication
2002
Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations
2006
The oral mucosa immune environment and oral transmission of HIV /SIV
2013
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Immunologic Control of HIV-1
2002
Viruses transfer the antiviral second messenger cGAMP between cells
2015 Science
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART
2007
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4 + T lymphocytes
2004
Towards an HIV cure: a global scientific strategy
2012
Viral Persistence: HIV's Strategies of Immune System Evasion
2002
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
2012
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Roles of substrate availability and infection of resting and activated CD4 + T cells in transmission and acute simian immunodeficiency virus infection
2004
Analysis of Human Immunodeficiency Virus Type 1 Gene Expression in Latently Infected Resting CD4 + T Lymphocytes In Vivo
2003
T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis
2004
Works of Deborah Persaud being referenced
Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy
2007
Neurocysticercosis in an Orthodox Jewish Community in New York City
1992
A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children
2000
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
2013
Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
2008
Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads
2004
Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 + T Cells
2006
Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads
2003
Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure
2002
The Challenge of Viral Reservoirs in HIV-1 Infection
2002
Latency in Human Immunodeficiency Virus Type 1 Infection: No Easy Answers
2003
Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay
1995
Identification of Ongoing Human Immunodeficiency Virus Type 1 (HIV-1) Replication in Residual Viremia during Recombinant HIV-1 Poxvirus Immunizations in Patients with Clinically Undetectable Viral Loads on Durable Suppressive Highly Active Antiretroviral Therapy
2009
A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+T Cells of Viremic Patients
2005
Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1
2004
Nosocomial Malaria and Saline Flush
2005
Delayed Recognition of Human Immunodeficiency Virus Infection in Preadolescent Children
1992